What is the recommended dose of amoxicillin (amoxicillin) for treating sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosing for Sinusitis

For acute bacterial sinusitis, the recommended dose of amoxicillin is 875 mg twice daily for 5-7 days, with high-dose amoxicillin-clavulanate (2000 mg amoxicillin component with 125 mg clavulanate twice daily) reserved for areas with high pneumococcal resistance or treatment failures. 1

Standard Dosing Regimens

  • First-line therapy:

    • Amoxicillin 875 mg twice daily for 5-7 days 1
    • Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
  • High-dose therapy (for areas with high pneumococcal resistance or treatment failures):

    • Amoxicillin-clavulanate 2000/125 mg (amoxicillin/clavulanate components) twice daily for 5-7 days 1

Patient Selection Considerations

When to use standard-dose amoxicillin:

  • Uncomplicated acute bacterial sinusitis
  • No recent antibiotic use (within past 4-6 weeks)
  • Areas with low pneumococcal resistance
  • No risk factors for resistant pathogens

When to use high-dose amoxicillin or amoxicillin-clavulanate:

  • Areas with high pneumococcal resistance (>10%)
  • Recent antibiotic use
  • Treatment failure with standard-dose therapy
  • Immunocompromised patients
  • Severe infection

Evidence for Dosing Recommendations

The European Position Paper on Rhinosinusitis (EPOS 2020) supports the use of amoxicillin 500 mg three times daily or amoxicillin-clavulanate 875/125 mg twice daily for acute bacterial sinusitis 2. However, more recent guidelines from the American Academy of Otolaryngology-Head and Neck Surgery recommend amoxicillin with or without clavulanate as first-line therapy for 5-10 days when antibiotics are deemed necessary 1.

Recent research suggests that immediate-release high-dose amoxicillin may lead to more rapid symptom improvement compared to standard dosing. In a 2018 randomized clinical trial, patients treated with immediate-release high-dose amoxicillin showed an 18% greater improvement rate at day 3 compared to standard-dose therapy (52.4% vs. 34.4%, p=0.04) 3. However, this benefit must be weighed against the increased risk of severe diarrhea (15.8% vs. 4.8%, p=0.048) 3.

Duration of Therapy

Current guidelines recommend a shorter duration of therapy (5-7 days) for uncomplicated acute bacterial sinusitis 1. This represents a shift from older recommendations of 10-14 days of treatment, as shorter courses have shown similar efficacy with reduced risk of antibiotic resistance and adverse effects.

Alternatives for Penicillin-Allergic Patients

For patients with penicillin allergy, the following alternatives are recommended:

  • Cefdinir 300-600 mg twice daily for 5-7 days
  • Cefuroxime 250-500 mg twice daily for 5-7 days
  • Cefpodoxime 200-400 mg twice daily for 5-7 days
  • Doxycycline (for severe penicillin allergy) 1

Important Clinical Considerations

  • Watchful waiting is appropriate for many patients with uncomplicated acute bacterial sinusitis, even those with more severe symptoms 1
  • Reassessment is necessary if the patient worsens or fails to improve within 7 days of initial management 1
  • Adjunctive therapies such as intranasal corticosteroids, saline nasal irrigation, and short-term nasal decongestants can be used alongside antibiotics to reduce inflammation and clear mucus 1
  • Avoid trimethoprim/sulfamethoxazole and azithromycin due to resistance patterns in common sinusitis pathogens 1

Monitoring and Follow-up

  • Assess for clinical improvement within 72 hours of starting antibiotics
  • Consider switching to a broader-spectrum antibiotic if no improvement is seen
  • Refer to specialist if signs of complications develop (orbital involvement, intracranial complications, persistent fever) 1

References

Guideline

Acute Bacterial Sinusitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.